3Blom IE, Goldschemding B, Leask A. Gene regulation of connective tissue growth factor: new target for antifibrotic therapy? Matrix Biology,2002, 21:473.
4Schiffer M, Gersdorff GV, Brrzer M et al. Smad proteins and trabsforming growth factor-β signaling. Kidney Int, 2000, 58:S45.
5Heusinger-Riberio J, Eberlein M, Wahab NA et al. Expression of connective tissue growth factor in human renal fibroblasts: Regulation of RhoA and cAMP. J Am Soc Neprol, 2001, 12:1953.
6Eberlein M, Heusinger-Riberio J, Goppelt-Struebe M. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors(statins).Bri J Pharma,2001,133:1172.
7Kucich U, rosenbloom JC,Herrick DJ et al.Signaling events required for transforming growth factor-β stimulation of connective tissue growth factor expression by cultured human lung fibroblasts. Arch Biochem Biophys, 2001, 374:313.
8Holmes A, Abraham DJ, Sa S et al. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem,2001, 276(14): 10594.
9Tomlinson DR. Mitogen-activated protein kinase as glucose transducers for diabetic complications. Diabetologia, 1999,42:1271.
10Hayashida T, Poncelet AC, Hubchak SC et al. TGF-β1 activate MAP kinase in human mesangial cells: A possible role in collagen expression.Kidney Int, 1999, 56:1710.
